Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-08

AUTHORS

Pär Stattin, Stefan Söderberg, Tommy Olsson, Göran Hallmans, Per Lenner, Carine Biessy, Rudolf Kaaks

ABSTRACT

Introduction. Obesity is associated with risk of breast cancer after menopause. Circulating levels of leptin are high in obesity and leptin stimulates growth of breast cancer cells.Material and methods. In a case-control study nested within the Northern Sweden Health and Disease Cohort, we measured leptin levels in prediagnostic plasma from 149 postmenopausal women who were diagnosed with breast cancer at a mean time 1.7 years (SD 2.0) after recruitment and among 258 control subjects.Results. No significant association between plasma levels of leptin and breast cancer risk was observed. Odds ratios (ORs) of breast cancer with increasing levels of leptin were 1.00 [referent], 1.01 [95% CI = 0.58–1.84], 0.65 [0.36–1.18], and 0.94 [0.53–1.67], and (pfor trend= 0.54). Adjustment for smoking, body mass index, and plasma insulin did not affect risk estimates.Discussion. These data do not support the hypothesis that plasma leptin is a risk factor for breast cancer. More... »

PAGES

191-196

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/b:brea.0000036782.11945.d7

DOI

http://dx.doi.org/10.1023/b:brea.0000036782.11945.d7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002978166

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15567935


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leptin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sweden", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology and Andrology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Urology and Andrology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stattin", 
        "givenName": "P\u00e4r", 
        "id": "sg:person.01216554525.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216554525.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Public Health and Clinical Medicine/Internal Medicine, Ume\u00e5 University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Public Health and Clinical Medicine/Internal Medicine, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "S\u00f6derberg", 
        "givenName": "Stefan", 
        "id": "sg:person.016465323374.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016465323374.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Public Health and Clinical Medicine/Internal Medicine, Ume\u00e5 University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Public Health and Clinical Medicine/Internal Medicine, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Olsson", 
        "givenName": "Tommy", 
        "id": "sg:person.012425401263.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012425401263.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Public Health and Clinical Medicine/Nutritional Research, Ume\u00e5 University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Public Health and Clinical Medicine/Nutritional Research, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hallmans", 
        "givenName": "G\u00f6ran", 
        "id": "sg:person.01023564410.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023564410.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Sciences/ Oncology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Radiation Sciences/ Oncology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lenner", 
        "givenName": "Per", 
        "id": "sg:person.0721051037.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.17703.32", 
          "name": [
            "International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Biessy", 
        "givenName": "Carine", 
        "id": "sg:person.01345317212.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345317212.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.17703.32", 
          "name": [
            "International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaaks", 
        "givenName": "Rudolf", 
        "id": "sg:person.015420102437.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015420102437.43"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2004-08", 
    "datePublishedReg": "2004-08-01", 
    "description": "Introduction. Obesity is associated with risk of breast cancer after menopause. Circulating levels of leptin are high in obesity and leptin stimulates growth of breast cancer cells.Material and methods. In a case-control study nested within the Northern Sweden Health and Disease Cohort, we measured leptin levels in prediagnostic plasma from 149 postmenopausal women who were diagnosed with breast cancer at a mean time 1.7 years (SD 2.0) after recruitment and among 258 control subjects.Results. No significant association between plasma levels of leptin and breast cancer risk was observed. Odds ratios (ORs) of breast cancer with increasing levels of leptin were 1.00 [referent], 1.01 [95% CI = 0.58\u20131.84], 0.65 [0.36\u20131.18], and 0.94 [0.53\u20131.67], and (pfor trend= 0.54). Adjustment for smoking, body mass index, and plasma insulin did not affect risk estimates.Discussion. These data do not support the hypothesis that plasma leptin is a risk factor for breast cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/b:brea.0000036782.11945.d7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "86"
      }
    ], 
    "keywords": [
      "levels of leptin", 
      "breast cancer risk", 
      "breast cancer", 
      "odds ratio", 
      "cancer risk", 
      "Northern Sweden Health", 
      "body mass index", 
      "case-control study", 
      "breast cancer cells", 
      "postmenopausal women", 
      "leptin levels", 
      "mass index", 
      "plasma leptin", 
      "prospective study", 
      "plasma insulin", 
      "prediagnostic plasma", 
      "control subjects", 
      "plasma levels", 
      "risk factors", 
      "disease cohort", 
      "leptin", 
      "significant association", 
      "cancer", 
      "risk estimates", 
      "cancer cells", 
      "obesity", 
      "risk", 
      "menopause", 
      "smoking", 
      "levels", 
      "cohort", 
      "insulin", 
      "women", 
      "study", 
      "association", 
      "health", 
      "subjects", 
      "cells", 
      "years", 
      "recruitment", 
      "adjustment", 
      "index", 
      "factors", 
      "plasma", 
      "northern Sweden", 
      "Sweden", 
      "hypothesis", 
      "data", 
      "ratio", 
      "growth", 
      "method", 
      "estimates", 
      "materials"
    ], 
    "name": "Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden", 
    "pagination": "191-196", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002978166"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/b:brea.0000036782.11945.d7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15567935"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/b:brea.0000036782.11945.d7", 
      "https://app.dimensions.ai/details/publication/pub.1002978166"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_381.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/b:brea.0000036782.11945.d7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/b:brea.0000036782.11945.d7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/b:brea.0000036782.11945.d7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/b:brea.0000036782.11945.d7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/b:brea.0000036782.11945.d7'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      20 PREDICATES      91 URIs      82 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/b:brea.0000036782.11945.d7 schema:about N31baa2f2f6f74f5eb9f191db1fa66142
2 N467d2265c04e41cd95d2ceb40a470190
3 N5132e652d7dd423b95680bfca538e775
4 N7b3ab0ddac5143d3930b68118f84dc98
5 N8a839b1a2d634b8e85bb1b9cba7853f9
6 N9c37bb5b5a5e4781a1e27bd5878a9df4
7 Nb63c6134947e4eecad6cf80d94fe4ba8
8 Nb9f1253700964571a69d44ea9f5d9bc5
9 Ncf0e79022b734a1aa4053f957c0f9ad1
10 Nd7e5d86a6fa446d09ac33ace064bcff7
11 Ne924547fa86f422ca9b10a650e968e5d
12 anzsrc-for:11
13 anzsrc-for:1112
14 anzsrc-for:1117
15 schema:author N69002f34b12c4ee88b667b0b3b82cef8
16 schema:datePublished 2004-08
17 schema:datePublishedReg 2004-08-01
18 schema:description Introduction. Obesity is associated with risk of breast cancer after menopause. Circulating levels of leptin are high in obesity and leptin stimulates growth of breast cancer cells.Material and methods. In a case-control study nested within the Northern Sweden Health and Disease Cohort, we measured leptin levels in prediagnostic plasma from 149 postmenopausal women who were diagnosed with breast cancer at a mean time 1.7 years (SD 2.0) after recruitment and among 258 control subjects.Results. No significant association between plasma levels of leptin and breast cancer risk was observed. Odds ratios (ORs) of breast cancer with increasing levels of leptin were 1.00 [referent], 1.01 [95% CI = 0.58–1.84], 0.65 [0.36–1.18], and 0.94 [0.53–1.67], and (pfor trend= 0.54). Adjustment for smoking, body mass index, and plasma insulin did not affect risk estimates.Discussion. These data do not support the hypothesis that plasma leptin is a risk factor for breast cancer.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N389162a4e1bd4bd09ed2a8198e5505a6
22 Nb3380a574a15435c86a717d40cc042fc
23 sg:journal.1092777
24 schema:keywords Northern Sweden Health
25 Sweden
26 adjustment
27 association
28 body mass index
29 breast cancer
30 breast cancer cells
31 breast cancer risk
32 cancer
33 cancer cells
34 cancer risk
35 case-control study
36 cells
37 cohort
38 control subjects
39 data
40 disease cohort
41 estimates
42 factors
43 growth
44 health
45 hypothesis
46 index
47 insulin
48 leptin
49 leptin levels
50 levels
51 levels of leptin
52 mass index
53 materials
54 menopause
55 method
56 northern Sweden
57 obesity
58 odds ratio
59 plasma
60 plasma insulin
61 plasma leptin
62 plasma levels
63 postmenopausal women
64 prediagnostic plasma
65 prospective study
66 ratio
67 recruitment
68 risk
69 risk estimates
70 risk factors
71 significant association
72 smoking
73 study
74 subjects
75 women
76 years
77 schema:name Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden
78 schema:pagination 191-196
79 schema:productId N0104815711f6461fbabc3bb177614d50
80 Ndd6a2314597d40608c83350c6a6bdc48
81 Ne5aa6657fc2942afb5485eed6caf1883
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002978166
83 https://doi.org/10.1023/b:brea.0000036782.11945.d7
84 schema:sdDatePublished 2022-10-01T06:32
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Nd3eeee26200543d1817d577ac82e9d96
87 schema:url https://doi.org/10.1023/b:brea.0000036782.11945.d7
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N0104815711f6461fbabc3bb177614d50 schema:name dimensions_id
92 schema:value pub.1002978166
93 rdf:type schema:PropertyValue
94 N2ab9639418a04b42bd50d8087b4be790 rdf:first sg:person.016465323374.03
95 rdf:rest Nf6f31669ab184c2da4bb0c2f55d4a8d6
96 N31baa2f2f6f74f5eb9f191db1fa66142 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Middle Aged
98 rdf:type schema:DefinedTerm
99 N389162a4e1bd4bd09ed2a8198e5505a6 schema:issueNumber 3
100 rdf:type schema:PublicationIssue
101 N467d2265c04e41cd95d2ceb40a470190 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Odds Ratio
103 rdf:type schema:DefinedTerm
104 N5132e652d7dd423b95680bfca538e775 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Case-Control Studies
106 rdf:type schema:DefinedTerm
107 N69002f34b12c4ee88b667b0b3b82cef8 rdf:first sg:person.01216554525.43
108 rdf:rest N2ab9639418a04b42bd50d8087b4be790
109 N74f7afb4c6b64b5db03f22c45a38fb36 rdf:first sg:person.015420102437.43
110 rdf:rest rdf:nil
111 N7b3ab0ddac5143d3930b68118f84dc98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Sweden
113 rdf:type schema:DefinedTerm
114 N83c76223f5b941329da07d8d7f398d14 rdf:first sg:person.01023564410.54
115 rdf:rest Ncf5abcfea7ea43848c4cb6140ded6203
116 N8a839b1a2d634b8e85bb1b9cba7853f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Aged
118 rdf:type schema:DefinedTerm
119 N9c37bb5b5a5e4781a1e27bd5878a9df4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Female
121 rdf:type schema:DefinedTerm
122 Nb3380a574a15435c86a717d40cc042fc schema:volumeNumber 86
123 rdf:type schema:PublicationVolume
124 Nb63c6134947e4eecad6cf80d94fe4ba8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Risk Factors
126 rdf:type schema:DefinedTerm
127 Nb9f1253700964571a69d44ea9f5d9bc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Prospective Studies
129 rdf:type schema:DefinedTerm
130 Ncf0e79022b734a1aa4053f957c0f9ad1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 Ncf5abcfea7ea43848c4cb6140ded6203 rdf:first sg:person.0721051037.52
134 rdf:rest Nddafaa1956414a1497766affb779297f
135 Nd3eeee26200543d1817d577ac82e9d96 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Nd7e5d86a6fa446d09ac33ace064bcff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Breast Neoplasms
139 rdf:type schema:DefinedTerm
140 Ndd6a2314597d40608c83350c6a6bdc48 schema:name pubmed_id
141 schema:value 15567935
142 rdf:type schema:PropertyValue
143 Nddafaa1956414a1497766affb779297f rdf:first sg:person.01345317212.46
144 rdf:rest N74f7afb4c6b64b5db03f22c45a38fb36
145 Ne5aa6657fc2942afb5485eed6caf1883 schema:name doi
146 schema:value 10.1023/b:brea.0000036782.11945.d7
147 rdf:type schema:PropertyValue
148 Ne924547fa86f422ca9b10a650e968e5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Leptin
150 rdf:type schema:DefinedTerm
151 Nf6f31669ab184c2da4bb0c2f55d4a8d6 rdf:first sg:person.012425401263.66
152 rdf:rest N83c76223f5b941329da07d8d7f398d14
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
157 schema:name Oncology and Carcinogenesis
158 rdf:type schema:DefinedTerm
159 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
160 schema:name Public Health and Health Services
161 rdf:type schema:DefinedTerm
162 sg:journal.1092777 schema:issn 0167-6806
163 1573-7217
164 schema:name Breast Cancer Research and Treatment
165 schema:publisher Springer Nature
166 rdf:type schema:Periodical
167 sg:person.01023564410.54 schema:affiliation grid-institutes:grid.412215.1
168 schema:familyName Hallmans
169 schema:givenName Göran
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023564410.54
171 rdf:type schema:Person
172 sg:person.01216554525.43 schema:affiliation grid-institutes:grid.412215.1
173 schema:familyName Stattin
174 schema:givenName Pär
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216554525.43
176 rdf:type schema:Person
177 sg:person.012425401263.66 schema:affiliation grid-institutes:grid.412215.1
178 schema:familyName Olsson
179 schema:givenName Tommy
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012425401263.66
181 rdf:type schema:Person
182 sg:person.01345317212.46 schema:affiliation grid-institutes:grid.17703.32
183 schema:familyName Biessy
184 schema:givenName Carine
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345317212.46
186 rdf:type schema:Person
187 sg:person.015420102437.43 schema:affiliation grid-institutes:grid.17703.32
188 schema:familyName Kaaks
189 schema:givenName Rudolf
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015420102437.43
191 rdf:type schema:Person
192 sg:person.016465323374.03 schema:affiliation grid-institutes:grid.412215.1
193 schema:familyName Söderberg
194 schema:givenName Stefan
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016465323374.03
196 rdf:type schema:Person
197 sg:person.0721051037.52 schema:affiliation grid-institutes:grid.412215.1
198 schema:familyName Lenner
199 schema:givenName Per
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52
201 rdf:type schema:Person
202 grid-institutes:grid.17703.32 schema:alternateName International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France
203 schema:name International Agency for Research on Cancer/Unit of Hormones and Cancer, Lyon, France
204 rdf:type schema:Organization
205 grid-institutes:grid.412215.1 schema:alternateName Department of Public Health and Clinical Medicine/Internal Medicine, Umeå University Hospital, Umeå, Sweden
206 Department of Public Health and Clinical Medicine/Nutritional Research, Umeå University Hospital, Umeå, Sweden
207 Department of Radiation Sciences/ Oncology, Umeå University Hospital, Umeå, Sweden
208 Department of Urology and Andrology, Umeå University Hospital, Umeå, Sweden
209 schema:name Department of Public Health and Clinical Medicine/Internal Medicine, Umeå University Hospital, Umeå, Sweden
210 Department of Public Health and Clinical Medicine/Nutritional Research, Umeå University Hospital, Umeå, Sweden
211 Department of Radiation Sciences/ Oncology, Umeå University Hospital, Umeå, Sweden
212 Department of Urology and Andrology, Umeå University Hospital, Umeå, Sweden
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...